Table 1. Number of controls and patients... | American Society of Hematology

Table 1.

Number of controls and patients in the different subgroups

Sex/Age (y)	Σ	Σ C	Σ C		Σ P	Σ P		CAD		Σ MI		1MI		>1MI
Sex/Age (y)	All	All	Phe	Tyr	All	Phe	Tyr	Phe	Tyr	Phe	Tyr	Phe	Tyr	Phe	Tyr
All	2197	417	378	39	1780	1602	178	773	92*	829	86	700	68	129	18
All > 55	1551	277	248	29	1274	1152	122	660	77*	492	45	435	41	57	4
All < 55	646	140	130	10	506	450	56	113	15	337	41	265	27	72	14
M, all	1531	212	192	20	1319	1187	132	533	65*	654	67	544	54	110	13
M > 55	1012	115	102	13	897	810	87	434	53*	376	34	329	31	47	3
M < 55	519	97	90	7	422	377	45	99	12	278	33	215	23	63	10
F, all	666	205	186	19	461	415	46	240	27	175	19	156	14	19	5
F > 55	539	162	146	16	377	342	35	226	24	116	11	106	10	10	1
F < 55	127	43	40	3	84	73	11	14	3	59	8	50	4	9	4

Sex/Age (y)	Σ	Σ C	Σ C		Σ P	Σ P		CAD		Σ MI		1MI		>1MI
Sex/Age (y)	All	All	Phe	Tyr	All	Phe	Tyr	Phe	Tyr	Phe	Tyr	Phe	Tyr	Phe	Tyr
All	2197	417	378	39	1780	1602	178	773	92*	829	86	700	68	129	18
All > 55	1551	277	248	29	1274	1152	122	660	77*	492	45	435	41	57	4
All < 55	646	140	130	10	506	450	56	113	15	337	41	265	27	72	14
M, all	1531	212	192	20	1319	1187	132	533	65*	654	67	544	54	110	13
M > 55	1012	115	102	13	897	810	87	434	53*	376	34	329	31	47	3
M < 55	519	97	90	7	422	377	45	99	12	278	33	215	23	63	10
F, all	666	205	186	19	461	415	46	240	27	175	19	156	14	19	5
F > 55	539	162	146	16	377	342	35	226	24	116	11	106	10	10	1
F < 55	127	43	40	3	84	73	11	14	3	59	8	50	4	9	4

Given are the numbers and the distribution of Phe-only and Tyr-carriers, respectively, assuming a dominant model.

Σ MI, all patients with MI; 1MI, patients with exactly 1 MI; >1MI, patients with more than 1 MI; C, controls; CAD, patients with CAD/without MI; F, female; M, male; P, patients.

The subgroup includes 2 Tyr homozygous patients

View Large

This Feature Is Available To Subscribers Only